Johnson & Johnson pauses COVID-19 vaccine trial over patient exhibiting an 'unexplained illness13/10/2020 The company released a statement on Monday, saying "We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 Ensemble trial, due to an unexplained illness in a study participant."
The study aimed to test 60,000 participants across the US, Argentina, Brazil and several other countries. In September, pharmaceutical company AstraZeneca paused clinical trials of an experimental COVID-19 vaccine after a participant in the UK had an unexplained illness, but the study has since resumed in the country.
0 Comments
Leave a Reply. |
Crossroads blogThe random thoughts of 99th Monkey . . . an occasional rant and other reflections in the hall of mirrors. Archives
October 2023
Categories |